News

Press ReleaseKing's College London spins out Korecyte Bio Ltd with investment and support from Cell and Gene Therapy Catapult to advance novel CAR-T platform for solid tumours
Filter:AllPress ReleaseCell TherapiesGene TherapiesDigital and AutomationSpin-outs, Start-ups, Sector investmentManufacturingRegulatory affairsSkills and Training
Year:All2026202520242023 →
Cell and Gene Therapy Catapult CEO to RetireCell and Gene Therapy Catapult CEO to RetirePress release: Construction completed on expansion phase, doubling capacity of Cell and Gene Therapy Catapult large scale manufacturing centre in StevenagePress release: Construction completed on expansion phase, doubling capacity of Cell and Gene Therapy Catapult large scale manufacturing centre in StevenageAugust news: Where will we see you this autumn?August news: Where will we see you this autumn?July news: Developing novel reimbursement practicesJuly news: Developing novel reimbursement practicesJune news: Supporting development of cell and gene therapiesJune news: Supporting development of cell and gene therapiesThe Duke of York visits the Cell and Gene Therapy CatapultThe Duke of York visits the Cell and Gene Therapy CatapultRegulatory news - August 2019Regulatory news - August 2019What are the hurdles impacting patient access to cell and gene therapies in the UK?What are the hurdles impacting patient access to cell and gene therapies in the UK?Regulatory news - July 2019Regulatory news - July 2019Press release: Annual Review 2019 highlights impact of CGT Catapult in accelerating the delivery of advanced therapies to patientsPress release: Annual Review 2019 highlights impact of CGT Catapult in accelerating the delivery of advanced therapies to patientsRegulatory news - June 2019Regulatory news - June 2019May news: Accelerating patient access to advance therapiesMay news: Accelerating patient access to advance therapies